Protagonist Therapeutics, Inc - Common Stock (PTGX)
CUSIP: 74366E102
Q1 2017 13F Holders as of 31 Mar 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 62,457,444
- Total 13F shares
- 8,008,863
- Share change
- +382,135
- Total reported value
- $102,590,269
- Price per share
- $12.81
- Number of holders
- 39
- Value change
- +$4,468,821
- Number of buys
- 17
- Number of sells
- 16
Quarterly Holders Quick Answers
What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74366E102:
Top shareholders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
4%
|
2,507,167
|
$55,133,000 | — | 31 Dec 2016 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.5%
|
1,531,076
|
$33,668,000 | — | 31 Dec 2016 | |
| Pharmstandard International S.A. |
13F
|
Company |
1.6%
|
983,570
|
$21,628,000 | — | 31 Dec 2016 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.2%
|
720,000
|
$15,833,000 | — | 31 Dec 2016 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.1%
|
692,563
|
$14,634,000 | — | 31 Dec 2016 | |
| Foresite Capital Management III, LLC |
13F
|
Company |
0.55%
|
346,281
|
$7,615,000 | — | 31 Dec 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.5%
|
310,079
|
$6,818,000 | — | 31 Dec 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.39%
|
244,386
|
$5,374,000 | — | 31 Dec 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
99,368
|
$2,185,000 | — | 31 Dec 2016 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
92,163
|
$2,028,000 | — | 31 Dec 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
82,180
|
$1,807,000 | — | 31 Dec 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
0.12%
|
72,987
|
$1,605,000 | — | 31 Dec 2016 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.07%
|
45,586
|
$1,002,000 | — | 31 Dec 2016 | |
| Graticule Asia Macro Advisors LLC |
13F
|
Company |
0.05%
|
31,827
|
$700,000 | — | 31 Dec 2016 | |
| Spark Investment Management LLC |
13F
|
Company |
0.05%
|
31,500
|
$692,000 | — | 31 Dec 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.05%
|
29,930
|
$658,000 | — | 31 Dec 2016 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.04%
|
22,918
|
$504,000 | — | 31 Dec 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
22,778
|
$501,000 | — | 31 Dec 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
22,715
|
$500,000 | — | 31 Dec 2016 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
15,700
|
$345,000 | — | 31 Dec 2016 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
13,200
|
$291,000 | — | 31 Dec 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
10,610
|
$233,000 | — | 31 Dec 2016 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.02%
|
9,461
|
$208,000 | — | 31 Dec 2016 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
7,638
|
$168,000 | — | 31 Dec 2016 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.01%
|
5,746
|
$126,000 | — | 31 Dec 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
5,219
|
$115,000 | — | 31 Dec 2016 | |
| Nationwide Fund Advisors |
13F
|
Company |
0.01%
|
4,934
|
$108,000 | — | 31 Dec 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
4,343
|
$94,000 | — | 31 Dec 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
2,758
|
$61,000 | — | 31 Dec 2016 | |
| STRS OHIO |
13F
|
Company |
0%
|
2,400
|
$52,000 | — | 31 Dec 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,443
|
$32,000 | — | 31 Dec 2016 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,343
|
$30,000 | — | 31 Dec 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,043
|
$23,000 | — | 31 Dec 2016 | |
| Creative Planning |
13F
|
Company |
0%
|
677
|
$15,000 | — | 31 Dec 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
357
|
$8,000 | — | 31 Dec 2016 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
363
|
$7,982 | — | 31 Dec 2016 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
262
|
$6,000 | — | 31 Dec 2016 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
218
|
$5,000 | — | 31 Dec 2016 |
Institutional Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q1 2017
As of 31 Mar 2017,
Protagonist Therapeutics, Inc - Common Stock (PTGX) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,008,863 shares.
The largest 10 holders included
FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Pharmstandard International S.A., Cormorant Asset Management, LLC, RA CAPITAL MANAGEMENT, LLC, Foresite Capital Management III, LLC, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
39
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
38
Q1 2017 holders
39
Holder diff
1
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 Value $ | Q1 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.